United Capital Financial Advisers, LLC Amgen Inc Transaction History

United Capital Financial Advisers, LLC

  • $13.5 Billion
  • Q3 2025

A detailed history of United Capital Financial Advisers, LLC transactions in Amgen Inc stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 84,536 shares of AMGN stock, worth $28.9 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
84,536
Previous 64,715 30.63%
Holding current value
$28.9 Million
Previous $18.1 Million 32.03%
% of portfolio
0.18%
Previous 0.15%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$271.18 - $309.22 $5.38 Million - $6.13 Million
19,821 Added 30.63%
84,536 $23.9 Million
Q2 2025

Aug 11, 2025
BUY
$262.28 - $309.85 $131,402 - $155,234
501 Added 0.78%
64,715 $18.1 Million
Q1 2025

May 13, 2025
BUY
$258.59 - $327.36 $1.62 Million - $2.05 Million
6,253 Added 10.79%
64,214 $20 Million
Q4 2024

Feb 13, 2025
SELL
$258.78 - $328.31 $1.94 Million - $2.46 Million
-7,489 Reduced 11.44%
57,961 $15.1 Million
Q3 2024

Nov 12, 2024
SELL
$309.38 - $337.38 $153,761 - $167,677
-497 Reduced 0.75%
65,450 $21.1 Million
Q2 2024

Aug 14, 2024
BUY
$262.75 - $319.31 $5.85 Million - $7.11 Million
22,271 Added 50.99%
65,947 $20.6 Million
Q1 2024

May 15, 2024
SELL
$268.87 - $324.56 $2.97 Million - $3.59 Million
-11,060 Reduced 20.21%
43,676 $12.4 Million
Q4 2023

Feb 14, 2024
SELL
$255.7 - $288.46 $11.9 Million - $13.5 Million
-46,714 Reduced 46.05%
54,736 $15.8 Million
Q3 2023

Nov 14, 2023
SELL
$218.65 - $271.46 $805,943 - $1 Million
-3,686 Reduced 3.51%
101,450 $27.3 Million
Q2 2023

Aug 14, 2023
SELL
$214.27 - $253.37 $1.62 Million - $1.92 Million
-7,578 Reduced 6.72%
105,136 $23.3 Million
Q1 2023

Aug 14, 2023
BUY
$225.79 - $275.2 $1.22 Million - $1.49 Million
5,420 Added 5.16%
110,556 $26.7 Million
Q1 2023

May 15, 2023
SELL
$225.79 - $275.2 $4.61 Million - $5.62 Million
-20,431 Reduced 15.34%
112,714 $27.2 Million
Q4 2022

Feb 14, 2023
SELL
$229.03 - $291.01 $1.21 Million - $1.53 Million
-5,267 Reduced 3.81%
133,145 $35 Million
Q3 2022

Nov 14, 2022
BUY
$224.46 - $253.15 $2.28 Million - $2.57 Million
10,146 Added 7.91%
138,412 $31.2 Million
Q2 2022

Aug 11, 2022
SELL
$230.71 - $256.74 $1.19 Million - $1.32 Million
-5,150 Reduced 3.86%
128,266 $31.2 Million
Q1 2022

May 16, 2022
BUY
$219.27 - $242.57 $216,419 - $239,416
987 Added 0.75%
133,416 $32.3 Million
Q4 2021

Feb 14, 2022
BUY
$198.88 - $227.6 $326,759 - $373,946
1,643 Added 1.26%
132,429 $29.8 Million
Q3 2021

Nov 15, 2021
BUY
$212.27 - $248.7 $159,202 - $186,525
750 Added 0.58%
130,786 $27.8 Million
Q2 2021

Aug 13, 2021
BUY
$233.58 - $259.14 $1.41 Million - $1.56 Million
6,036 Added 4.87%
130,036 $31.7 Million
Q1 2021

May 14, 2021
BUY
$221.91 - $258.6 $2.85 Million - $3.32 Million
12,846 Added 11.56%
124,000 $30.9 Million
Q4 2020

Feb 17, 2021
BUY
$216.38 - $257.67 $1.07 Million - $1.27 Million
4,924 Added 4.64%
111,154 $25.6 Million
Q3 2020

Nov 13, 2020
BUY
$234.65 - $260.95 $805,553 - $895,841
3,433 Added 3.34%
106,230 $27 Million
Q2 2020

Aug 13, 2020
SELL
$197.81 - $242.74 $23.5 Million - $28.8 Million
-118,609 Reduced 53.57%
102,797 $24.2 Million
Q1 2020

May 15, 2020
SELL
$182.24 - $241.7 $64,330 - $85,320
-353 Reduced 0.16%
221,406 $43.9 Million
Q4 2019

Feb 14, 2020
BUY
$189.21 - $243.2 $2.97 Million - $3.81 Million
15,671 Added 7.6%
221,759 $53.5 Million
Q3 2019

Nov 14, 2019
SELL
$174.11 - $208.62 $5.26 Million - $6.3 Million
-30,211 Reduced 12.79%
206,088 $39.9 Million
Q2 2019

Aug 13, 2019
SELL
$166.7 - $195.41 $575,281 - $674,359
-3,451 Reduced 1.44%
236,299 $43.5 Million
Q1 2019

May 14, 2019
BUY
$180.87 - $203.88 $1.34 Million - $1.51 Million
7,419 Added 3.19%
239,750 $45.5 Million
Q4 2018

Feb 14, 2019
SELL
$178.4 - $208.25 $7.94 Million - $9.27 Million
-44,528 Reduced 16.08%
232,331 $45.2 Million
Q3 2018

Nov 14, 2018
BUY
$185.29 - $208.89 $1.04 Million - $1.17 Million
5,618 Added 2.07%
276,859 $57.4 Million
Q2 2018

Aug 14, 2018
BUY
$166.05 - $186.51 $2.16 Million - $2.43 Million
13,020 Added 5.04%
271,241 $50.1 Million
Q1 2018

May 15, 2018
BUY
$169.43 - $198.0 $16.5 Million - $19.3 Million
97,669 Added 60.83%
258,221 $44 Million
Q4 2017

Feb 13, 2018
BUY
$168.79 - $188.59 $397,838 - $444,506
2,357 Added 1.49%
160,552 $28.1 Million
Q3 2017

Nov 14, 2017
BUY
$167.29 - $191.0 $20.8 Million - $23.8 Million
124,552 Added 370.22%
158,195 $29.5 Million
Q2 2017

Aug 14, 2017
BUY
N/A
33,643
33,643 $5.79 Million

Others Institutions Holding AMGN

# of Institutions
3,274
Shares Held
428M
Call Options Held
6.11M
Put Options Held
5.85M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email